Literature DB >> 24142676

Is metabolic syndrome related with coronary artery disease severity and complexity: An observational study about IDF and AHA/NHLBI metabolic syndrome definitions.

Ahmet Çağrı Aykan1, İlker Gül, Ezgi Kalaycıoğlu, Tayyar Gökdeniz, Engin Hatem, Ümit Menteşe, Banu Şahin Yıldız, Mustafa Yıldız.   

Abstract

BACKGROUND: The aim of the present study was to assess the relation between metabolic syndrome (MS) and coronary artery disease (CAD) complexity, assessed by Syntax score (SS), and severity in non-diabetic patients with stable CAD who underwent coronary angiography, and to evaluate whether the MS defined by different definitions, including International Diabetes Federation (IDF) and American Heart Association/National Heart Lung Blood Institute (AHA/NHLBI) guidelines, similarly correlated with SS.
METHODS: The present study is cross sectional and observational with prospective inclusion of 248 consecutive patients (157 male) who underwent coronary angiography due to stable CAD.
RESULTS: The prevalence of MS was 54.4% according to IDF definition and 50.4% according to AHA/NHLBI definition. MS score according to IDF definitions (r = 0.446, p < 0.001), MS score according to AHA/NHLBI definitions (r = 0.341, p < 0.001) were moderately correlated with SS. In Fisher r to z transformation test the correlations of the presence of MS according to IDF and AHA/NHLBI definitions with SS were not statistically significant (p = 0.168, z = -1.38). The systolic blood pressure (p < 0.001, B = 0.354, 95% CI = -0.308 to 0.228), diastolic blood pressure (p = 0.006, B = -0.194, 95% CI = -0.333 to -0.056), age (p = 0.014, B = 0.147, 95% CI = 0.029 to 0.264), left ventricular ejection fraction (p = 0.031, B = -0.150, 95% CI= -0.286 to -0.014), waist/hip circumference (p < 0.001, B = 45.713, 95% CI = 23.235 to 68.1919) and log10 high density lipoprotein (p < 0.001, B = -22.209, 95% CI = -33.298 to-11.119) were the independent predictors of SS in linear regression analysis.
CONCLUSIONS: MS is associated with the presence and complexity of CAD. Besides the presence of discrepancy in the limits of waist circumference, both IDF and AHA/NHLBI criteria were similarly correlated with CAD complexity.

Entities:  

Mesh:

Year:  2013        PMID: 24142676     DOI: 10.5603/CJ.a2013.0126

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  7 in total

1.  Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.

Authors:  Jie You; Wen-Yue Liu; Gui-Qi Zhu; Ou-Chen Wang; Rui-Min Ma; Gui-Qian Huang; Ke-Qing Shi; Gui-Long Guo; Martin Braddock; Ming-Hua Zheng
Journal:  Oncotarget       Date:  2015-08-14

2.  The value of wrist circumference for predicting the presence of coronary artery disease and metabolic syndrome.

Authors:  Shokoufeh Hajsadeghi; Ata Firouzi; Pouria Bahadoran; Morteza Hassanzadeh
Journal:  Indian Heart J       Date:  2016-11-05

3.  Author`s Reply.

Authors:  Ahmet Çağrı Aykan
Journal:  Anatol J Cardiol       Date:  2016-07       Impact factor: 1.596

4.  The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females.

Authors:  Zhou-Feng Chen; Xiu-Li Dong; Qing-Ke Huang; Wang-Dong Hong; Wen-Zhi Wu; Jian-Sheng Wu; Shuang Pan
Journal:  World J Surg Oncol       Date:  2018-08-10       Impact factor: 2.754

5.  Shift work and the relationship with metabolic syndrome in Chinese aged workers.

Authors:  Yanjun Guo; Yi Rong; Xiji Huang; Hanpeng Lai; Xin Luo; Zhihong Zhang; Yuewei Liu; Meian He; Tangchun Wu; Weihong Chen
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

6.  Interaction of smoking and metabolic syndrome in increasing the recurrence risk of colorectal cancer in a Chinese male cohort: a retrospective study.

Authors:  Da-Zhi Chen; Fei-Yang Ji; Qiao-Mai Xu; Xiao-Xin Wu; Chao Cai; Ling-Jian Zhang; Lan-Juan Li
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

7.  Ivabradine for coronary artery disease and/or heart failure-a protocol for a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.

Authors:  M Maagaard; E E Nielsen; C Gluud; J C Jakobsen
Journal:  Syst Rev       Date:  2019-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.